Li W - Search Results

1

Metabolic Engineering of Pichia pastoris for High-Level Production of Lycopene.

Zhang X, Chen S, Lin Y, Li W, Wang D, Ruan S, Yang Y, Liang S. Zhang X, et al. Among authors: li w. ACS Synth Biol. 2023 Oct 20;12(10):2961-2972. doi: 10.1021/acssynbio.3c00294. Epub 2023 Oct 2. ACS Synth Biol. 2023. PMID: 37782893

2

Causal modulation of lipid metabolism may shape the inflammatory microenvironment and potentially augment immunotherapy: a comprehensive genetic landscape revealed by Mendelian randomization analysis.

Li W, Wang W. Li W, et al. Int Immunol. 2024 Apr 27;36(6):291-302. doi: 10.1093/intimm/dxae008. Int Immunol. 2024. PMID: 38451254

3

Dietary astaxanthin alleviates black soldier fly oil-induced negative changes of fatty acids content and muscle quality on Oncorhynchus mykiss via mammalian target of rapamycin and AMP-activated protein kinase pathway.

Chen Y, Zhong J, Chen X, Li X, Pu H, Chen B, Guo Y, Chen A, Li W, Hu P, Zhu X, Zhao W, Niu J. Chen Y, et al. Among authors: li w, li x. Anim Nutr. 2024 Sep 26;19:313-324. doi: 10.1016/j.aninu.2024.07.005. eCollection 2024 Dec. Anim Nutr. 2024. PMID: 39640547 Free PMC article.

4

Adverse events of concomitant use of immune checkpoint inhibitors and metformin or statin: an observational, retrospective disproportionality analysis.

Li W, Wang W. Li W, et al. Expert Opin Drug Saf. 2025 Apr 18:1-10. doi: 10.1080/14740338.2025.2494684. Online ahead of print. Expert Opin Drug Saf. 2025. PMID: 40232293

5

Toxicity profiles associated with EGFR-TKIs combined with angiogenesis inhibitors in non-small cell lung cancer: an epidemiological surveillance analysis of the FDA adverse event reporting system.

Li W, Lv R, Wang W. Li W, et al. Expert Opin Drug Saf. 2024 Sep 11:1-10. doi: 10.1080/14740338.2024.2399082. Online ahead of print. Expert Opin Drug Saf. 2024. PMID: 39262117

6

Decoding the genetic links between serum lipidomic profile, amino acid biomarkers, and programmed cell death protein-1/programmed cell death-ligand-1.

Li W, Wang W. Li W, et al. Cancer Immunol Immunother. 2023 Oct;72(10):3395-3399. doi: 10.1007/s00262-023-03501-8. Epub 2023 Jul 27. Cancer Immunol Immunother. 2023. PMID: 37498324 Free PMC article.

7

MASLD may influence female-specific cancer risk indirectly through shared metabolic pathways rather than direct causation.

Li W, Lv R. Li W, et al. Metabolism. 2025 Jun 4:156322. doi: 10.1016/j.metabol.2025.156322. Online ahead of print. Metabolism. 2025. PMID: 40480452 No abstract available.

8

Insights into risk factors for basal cell carcinoma: a Mendelian randomization study.

Li W, Wang W. Li W, et al. Clin Exp Dermatol. 2023 Jun 5;48(6):676-680. doi: 10.1093/ced/llad046. Clin Exp Dermatol. 2023. PMID: 36815291

9

A real-world analysis of tyrosine receptor kinase inhibitor-related toxicities in cancer treatment.

Li W, Wen K, Zhu W, Luo S. Li W, et al. Per Med. 2023 Nov;20(6):485-491. doi: 10.2217/pme-2023-0072. Epub 2023 Nov 1. Per Med. 2023. PMID: 37909303

10

Unraveling the genetic associations between PD-1/PD-L1 and 13 circulating biomarkers linked to physiological and pathological processes.

Li W, Wang W. Li W, et al. Clin Transl Oncol. 2024 May;26(5):1157-1169. doi: 10.1007/s12094-023-03333-z. Epub 2023 Nov 16. Clin Transl Oncol. 2024. PMID: 37971626

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87,959 results

Search Page

Filters